Atlas Trials

A Pharmacogenomics Study for Breast Cancer Patients Undergoing Adjuvant Chemotherapy With Doxorubicin (A)/Cyclophosphamide ©) and/or Weekly Paclitaxel

Clinical trial NCT00131963 · COMPLETED

Trial details

NCT number
NCT00131963
Sponsor
Duke University
Status
COMPLETED
Study type
OBSERVATIONAL
Breast Cancer
Start date
2003-10-01
Primary completion
2014-10-01
Enrollment
94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.